Adding a Reverser (Verapamil) to Combined Chemotherapy Overrides Resistance in Small Cell Lung Cancer Xenografts

Author: Arvelo F.   Bichat F.   Grossin F.   Bourgeois Y.   Jacrot M.   Bastian G.   Poupon M.F.   Le Chevalier T.  

Publisher: Elsevier

ISSN: 0959-8049

Source: European Journal of Cancer, Vol.31, Iss.11, 1995-10, pp. : 1862-1868

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content